Date | Title | Description | |
---|---|---|---|
24 Feb 2021 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
27 Nov 2020 | On business and financial situation | The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia | Download |
09 Jul 2020 | On business and financial situation | ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate | Download |
Pages
Date | Title | Description | |
---|---|---|---|
11 May 2022 | On Corporate Governance | The Company informs about the appointment of a new member in its Board of Directors | Download |
11 May 2022 | On business and financial situation | The Company releases the press release related to the first quarter 2022 financial result | Download |
11 May 2022 | On business and financial situation | The Company releases the first quarter 2022 financial results presentation | Download |
11 May 2022 | Announcement of general shareholders’ meeting | Rovi releases the information related to its 2022 General Shareholders Meeting | Download |
05 Apr 2022 | Liquidity and counterparty agreements | The Company communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
30 Jul 2014 | información sobre resultados | Download | |
30 Jul 2014 | información sobre resultados (2) | Download | |
01 Jul 2014 | Información sobre dividendos | Download | |
12 Jun 2014 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
29 Apr 2014 | Información sobre resultados (2) | Download |